Table of Content


1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customers
5. Turkey Generic Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Type (Small Molecule Generics and Biosimilars)
5.2.2. By Mode of Drug Delivery (Oral, Parenteral, Topical, Others)
5.2.3. By Form (Tablets, Capsules, Injections, Others)
5.2.4. By Source (Contract Manufacturing Organizations and In-House Manufacturing)
5.2.5. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others)
5.2.6. By Application (Cardiovascular Diseases, Diabetes, Oncology, Neurology, Anti-Inflammatory Diseases, Others)
5.2.7. By Region
5.2.8. By Company (2022)
5.3. Market Map
6. Turkey Small Molecule Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mode of Drug Delivery
6.2.2. By Form
6.2.3. By Source
6.2.4. By Distribution Channel
6.2.5. By Application
7. Turkey Biosimilar Molecule Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Volume
7.2.3. By Material
7.2.4. By End User
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends & Developments
10. Policy & Regulatory Landscape
11. Import-Export Analysis
12. Turkey Economic Profile
13. Competitive Landscape
13.1. AbbVie T?rkiye
13.2. Amgen Inc.
13.3. Bilim Pharmaceuticals
13.4. Bristol-Myers Squibb Company
13.5. EastPharma Ltd
13.6. Ferring ?lac Sanayi ve Ticaret Ltd Sti (Ferring Global)
13.7. Gensenta ?la? Sanayi ve Ticaret A.?.
13.8. GlaxoSmithKline Turkey
13.9. ITALFARMACO S.p.A.
13.10. Menarini T?rkiye (Menarini Group)
13.11. Merck & Co.
13.12. MS Pharma
13.13. Novartis Turkey
13.14. Pfizer Turkey
13.15. Takeda Pharmaceutical Company
14. Strategic Recommendations